Tempus AI

So Tempus has stepped in, combining large-scale clinical and molecular data with AI to help doctors make more informed treatment decisions, while giving pharma and biotech companies tools to discover targets, design trials and develop drugs. Its platform spans everything from genomic testing and clinical-trial matching to AI assistants and real-world data analysis - essentially trying to turn healthcare's mountain of data into something people can actually use.

The company already has 19 out of 20 of the largest biopharma companies building with it, more than 8.5M de0identified research records, and has documents a 5x ROI on programs using its Lens platforms. Its ambition is bigger still, and it wants to make AI-enabled precision medicine a core part of how healthcare and drug development work, moving from simply analysing data to helping shape what happens next.